Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harte Hanks (HHS) Total Liabilities (2016 - 2025)

Harte Hanks has reported Total Liabilities over the past 16 years, most recently at $71.3 million for Q4 2025.

  • Quarterly Total Liabilities fell 10.98% to $71.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $71.3 million through Dec 2025, down 10.98% year-over-year, with the annual reading at $71.3 million for FY2025, 10.98% down from the prior year.
  • Total Liabilities was $71.3 million for Q4 2025 at Harte Hanks, down from $72.8 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $161.6 million in Q1 2021 and troughed at $71.3 million in Q4 2025.
  • The 5-year median for Total Liabilities is $94.0 million (2023), against an average of $102.9 million.
  • The largest YoY upside for Total Liabilities was 8.6% in 2021 against a maximum downside of 24.58% in 2021.
  • A 5-year view of Total Liabilities shows it stood at $122.9 million in 2021, then fell by 17.64% to $101.2 million in 2022, then rose by 1.7% to $102.9 million in 2023, then dropped by 22.16% to $80.1 million in 2024, then fell by 10.98% to $71.3 million in 2025.
  • Per Business Quant, the three most recent readings for HHS's Total Liabilities are $71.3 million (Q4 2025), $72.8 million (Q3 2025), and $72.8 million (Q2 2025).